Filing Details

Accession Number:
0000950170-24-070965
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-07 18:34:21
Reporting Period:
2024-06-05
Accepted Time:
2024-06-07 18:34:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593899 Atea Pharmaceuticals Inc. AVIR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296995 Jean-Pierre Sommadossi 225 Franklin Street
Suite 2100
Boston MA 02110
President, Ceo, And Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-05 1,006 $4.00 5,923,994 No 4 S Indirect Held by JPM Partners LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by JPM Partners LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 116,557 Direct